Literature DB >> 21690038

[Endogenous neuregulin-1 expression in the anterior pituitary of female Wistar-Furth rats during the estrous cycle].

Wei-jiang Zhao1, Song-guang Ren.   

Abstract

OBJECTIVE: To study the changes in endogenous neuregulin-1 (Nrg1) expression in the anterior pituitary of female Wistar-Furth rats in different phases of the estrous cycle.
METHODS: Female Wistar-Furth rats during estrous cycles were used. RT-PCR was employed to study the changes in the expression of Nrg1 isoforms and their cognate receptors ErbB-2 and ErbB-4 in the anterior pituitary in different phases of the estrous cycle. Western blotting was used to detect Nrg1 expression at the protein level. Immunofluorescence staining was used to identify hypophyseal cells expressing Nrg1 and observe the localization and distribution of Nrg1 and functional phosphorylation of ErbB-4. The co-expression of Nrg1 and ErbB-4 in the anterior pituitary of Rhesus monkey was also investigated.
RESULTS: Some of the Nrg1 isoforms, especially type III Nrg1s, were expressed at a higher level during the estrous cycle I (E1) and estrous cycle II (E2), a result consistent with that of Western blotting for samples of the anterior pituitaries collected at these phases. Immunofluorescence staining identified the gonadotrophs as the main source of Nrg1, and showed an extensive distribution of Nrg1 in the anterior pituitary in E1 and E2 phases accompanied by apparent phosphorylated activation of ErbB-4. Adjacent distribution of Nrg1- and ErbB-4-positive cells was also observed in the anterior pituitary of male Rhesus monkeys.
CONCLUSION: Our results provide evidence for the expression of multiple Nrg1 isoforms and the presence of Nrg1/ErbB-4 signaling in the anterior pituitary of female Wistar-Furth rats. This signaling demonstrates an estrous cycle phase-related pattern. Additionally, Nrg1/ErbB-4-based juxtacrine signaling may exist in the anterior pituitary of male non-human primate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690038

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  8 in total

1.  The interaction of disrupted type II neuregulin 1 and chronic adolescent stress on adult anxiety- and fear-related behaviors.

Authors:  S B Taylor; A R Taylor; J I Koenig
Journal:  Neuroscience       Date:  2012-09-25       Impact factor: 3.590

2.  [Neuregulin 2 is highly expressed in glioma tissues to regulate glial fibrillary acidic protein expression via Akt signaling].

Authors:  W Zhao; J Lin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-08-20

3.  Comparison of L1 expression and secretion in glioblastoma and neuroblastoma cells.

Authors:  Weijiang Zhao
Journal:  Oncol Lett       Date:  2012-07-05       Impact factor: 2.967

4.  Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease.

Authors:  Qiong Jiang; Shuangxi Chen; Chengliang Hu; Peizhi Huang; Huifan Shen; Weijiang Zhao
Journal:  Mol Med Rep       Date:  2016-07-25       Impact factor: 2.952

5.  CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.

Authors:  Zhai Yang; Qing Xie; Cheng-Liang Hu; Qiong Jiang; Hui-Fan Shen; Melitta Schachner; Wei-Jiang Zhao
Journal:  Front Mol Neurosci       Date:  2017-10-17       Impact factor: 5.639

6.  Identification of novel biomarkers for prediction of neurological prognosis following cardiac arrest.

Authors:  Jung Woo Eun; Hee Doo Yang; Soo Hyun Kim; Sungyoup Hong; Kyu Nam Park; Suk Woo Nam; Sikyoung Jeong
Journal:  Oncotarget       Date:  2017-03-07

7.  Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey.

Authors:  Wei-Jiang Zhao
Journal:  Int J Endocrinol Metab       Date:  2013-07-01

8.  Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model.

Authors:  Zhai Yang; Qiong Jiang; Shuang-Xi Chen; Cheng-Liang Hu; Hui-Fan Shen; Pei-Zhi Huang; Jun-Ping Xu; Jin-Ping Mei; Ben-Ping Zhang; Wei-Jiang Zhao
Journal:  Mol Med Rep       Date:  2016-05-23       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.